Contact this trialFirst, we need to learn more about you.
Integrase Inhibitor, Non-Nucleoside Reverse Transcriptase Inhibitor
CAB LA plus RPV LA +1 More for Human Immunodeficiency Virus Infection
Recruiting1 awardPhase 2
Montreal, Quebec
This trial will study the effects of an experimental antiviral drug given as an injection every two months, in people who have HIV and are already taking other antiviral medications. The trial will last until the drug regimen receives regulatory approval and becomes commercially available, and will enroll approximately 100 participants.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.